Drugs and obesuty Drugs industry and obesity: an analysis to Cholesterol products

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorAbdou, Doaa M. Salman
dc.contributor.authorAli, Dina
dc.date.accessioned2021-02-08T09:51:29Z
dc.date.available2021-02-08T09:51:29Z
dc.date.issued2020-02
dc.description.abstractThe paper discusses the market by seeing two medicines which are Niaspan and Zetia that decrease the cholesterol in the body. Through the paper, we will see that both the drugs are considered to be oligopoly market competition followed by the market analysis of the cholesterol medicine in the US from 2011 till 2013 and to check the elasticity of demand from the demand the curve for both the drugs. Later, we come to see the factors that affect the demand and supply for Niaspan and Zetia. Lastly, we end the paper with a conclusion about future expectations and suggestions for the pharmaceutical medicines that can enhance their performances.en_US
dc.identifier.other10.26689/pbes.v3i1.901
dc.identifier.urihttp://repository.msa.edu.eg/xmlui/handle/123456789/4420
dc.language.isoen_USen_US
dc.publisherBIM-BYWORDen_US
dc.relation.ispartofseriesProceedings of Business and Economic Studies;Volume 3; Issue 1
dc.subjectOctober University for economicen_US
dc.titleDrugs and obesuty Drugs industry and obesity: an analysis to Cholesterol productsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
901-Article Text-2820-1-10-20200306.pdf
Size:
287.47 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: